Venetoclax and low-dose cytarabine induced complete remissionin a patient with high-risk acute myeloid leukemia： a case report 被引量：2

导出

作者 Bingshan Liu Roshni Narurkar Madhura Hanmantgad Wahib Zafar Yongping Song Delong Liu

机构地区 The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Department of Medicine

出处《Frontiers of Medicine》 SCIE CAS CSCD 2018年第5期593-599,共7页 医学前沿（英文版）

基金 This project was partly supported by the Zhengzhou University Training Grant （BL） and the National Natural Science Foundation of China （No. 81470287, YPS）. BL is a recipient of 2017 CAHON Young Investigator Award （www.cahon.org）.

分类号 R [医药卫生]

引文网络
相关文献

同被引文献1

1李军民.老年急性髓系白血病患者的治疗策略[J].临床血液学杂志,2019,32(3):327-331. 被引量：7

引证文献2

1Wei Shi,Weiwei Jin,Linghui Xia,Yu Hu.Novel agents targeting leukemia cells and immune microenvironment for prevention and treatment of relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation[J].Acta Pharmaceutica Sinica B,2020,10(11):2125-2139. 被引量：7
2雷芳,费小明,陆益龙,王丽霞,余先球,陈婉如,蒋茜,汤郁.Venetoclax联合化疗治疗难治/复发急性髓系白血病8例并文献复习[J].临床血液学杂志,2021,34(1):44-47. 被引量：6

二级引证文献13

1Huile Gao,Zhiqing Pang,Wei He.Editorial of Special Issue on Tumor Microenvironment and Drug Delivery[J].Acta Pharmaceutica Sinica B,2020,10(11):2016-2017.
2张凝,吉训琦,符小妹,钟志娟.venetoclax联合LDAC方案治疗复发儿童急性髓系白血病1例[J].中国肿瘤临床,2021,48(9):486-486. 被引量：2
3Chaoyue Su,Jianye Zhang,Yosef Yarden,Liwu Fu.The key roles of cancer stem cell-derived extracellular vesicles[J].Signal Transduction and Targeted Therapy,2021,6(4):1142-1156. 被引量：2
4吴俣,张昕.急性髓细胞白血病精准治疗时代的医患共同决策[J].西部医学,2021,33(10):1405-1411. 被引量：5
5盘婉盈,张映璇,涂三芳,黄睿,郭梦琪,何颖芝,杜静文,宋朝阳,李玉华,黄宇贤.Venetoclax联合去甲基化药物治疗复发/难治性急性髓系白血病的疗效及预后分析[J].临床血液学杂志,2021,34(9):650-654. 被引量：7
6俞方泉.中西医结合单元疗法治疗老年急性髓系白血病的效果观察[J].中华养生保健,2021,39(12):32-34. 被引量：1
7张霞,杨华强,覃骏,李红,余帮伟,王黎,戢操.维奈克拉联合阿扎胞苷桥接异基因造血干细胞移植治疗难治急性单核细胞白血病一例并文献复习[J].白血病．淋巴瘤,2021,30(11):692-694. 被引量：4
8王萍,高红秀,任晓艳,郭力,吴胜胜,陆娟.Venetoclax联合LDAC方案治疗复发难治性急性髓细胞白血病的疗效及对血清VEGF、survivin表达水平的影响[J].实用癌症杂志,2022,37(2):341-344. 被引量：6
9杨兆娜,王凤,张婷婷,李平平,李珂,崔冰.白血病骨髓微环境研究进展[J].药学学报,2022,57(9):2601-2611. 被引量：8
10孙甜,李秀军.基于扶正透毒法论治急性髓系白血病[J].贵州中医药大学学报,2023,45(4):1-4. 被引量：4

1陈鹏,陈小平.急性髓系白血病治疗药物的药物基因组学研究进展[J].药学进展,2018,42(4):259-268. 被引量：1
2Wen-Jian Shi,Yu-Xuan Zhang,Gui-Ping Xu,Qing-Jun Ma,Jian-Hua Qin,Xin-Hua Wu,Li Wang.Extracorporeal Membrane Oxygenation-Assisted Percutaneous Coronary Intervention in Extremely High-Risk Patients[J].Chinese Medical Journal,2018(13):1625-1627. 被引量：2
3韩奇,李琴芳.HR-HPV联合液基细胞学在宫颈癌诊断中的价值[J].浙江创伤外科,2018,23(3):526-527. 被引量：1
4Nikolay N. ILOV,Anatoly A. NECHEPURENKO,Albert M. ABDULKADYROV,Damir R. PASKEEV,Timur F. ASFANDIYAROV,Dmitry G. TARASOV.CIED implantation in elderly patients： a single-center experience[J].Journal of Geriatric Cardiology,2018,15(6):460-462.
5崔佳奇,邓琳丽,王利.miR-143增强SKM-1细胞对阿糖胞苷的药物敏感性[J].中国细胞生物学学报,2018,40(7):1153-1158. 被引量：1
6黄环,粟伟栋,谭红.高危非致残性缺血性脑血管事件治疗进展[J].神经病学与神经康复学杂志,2018,14(1):33-37. 被引量：3
7陈星,戢敏,刘娇,王川林,梅怡晗,敬雪明.静脉置管模式对恶性血液病患者导管相关血流感染的影响及危险因素分析[J].川北医学院学报,2018,33(2):271-275. 被引量：7
8张蔚苓,赵珊琼.高危型人乳头瘤病毒感染的相关危险因素分析[J].中国现代医生,2018,56(19):57-60. 被引量：4
9Zong-Ming Zhang,Jia-Hong Dong,Fang-Cai Lin,Qiu-Sheng Wang,Zhi Xu,Xiao-Dong He,Chong Zhang,Zhuo Liu,Li-Min Liu,Hai Deng,Hong-Wei Yu,Bai-Jiang Wan,Ming-Wen-Zhu,Hai-Yan Yang,Meng-Meng Song,Yue Zhao.Current Status of Surgical Treatment of Biliary Diseases in Elderly Patients in China[J].Chinese Medical Journal,2018(15):1873-1876. 被引量：16
10YAN Han,ZHANG Dao-yu,LI Xi,YUAN Xiao-qing,YANG Yong-ong,ZHU Ke-wei,ZENG Hui,LI Xiao-in,ZHOU Hong-hao,ZHANG Wei,CHEN Xiao-ping.A polymorphism in GAS5 promoter impacts efficacy of cytarabine-based chemotherapy in Chinese AML patients[J].中国药理学与毒理学杂志,2016,30(10):1077-1077.

Frontiers of Medicine

2018年第5期

浏览历史

内容加载中请稍等...

Venetoclax and low-dose cytarabine induced complete remissionin a patient with high-risk acute myeloid leukemia： a case report 被引量：2

同被引文献1

引证文献2

二级引证文献13

相关作者

相关机构

相关主题

浏览历史